A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

NCT06831058 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Immune-mediated Thrombotic Thrombocytopenic Purpura

Interventions

DRUG: efgartigimod

Sponsor

University of Minnesota